UK and Russia sign MoU on regulatory co-operation on medicines29 Jan 2019
Medicines regulators of the UK and Russian set out key principles to support their collaboration on improving public health.
The Medicines and Healthcare products Regulatory Agency (MHRA) has signed a Memorandum of Understanding (MoU) with its Russian counterpart; the State Institute of Drugs and Good Practices of the Ministry of Industry and Trade of the Russian Federation.
This agreement will increase collaboration between the two bodies and further enhance co-operation in the field of regulation of medicines.
The MoU is designed to establish mechanisms of cooperation which will facilitate:
Dr Sam Atkinson, MHRA’s Director of the Inspection, Enforcement and Standards Division, said: "Working in an increasingly global environment, the sharing of intelligence between medicines regulators is the cornerstone of protecting the health system worldwide.
"Formalising our already close working relationships with international counterparts helps facilitate this exchange of information.
"This makes it easier for us to track down criminals, promote good practices internationally, and identify emerging safety trends to protect public health."
Pharmapack Europe 2019 Award Winners
7 Feb 2019
Awards showcased a wide range of industry-changing discoveries in drug delivery, packaging and automation.Read more
Brexit - the EU FMD's painful problem
7 Feb 2019
Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.Read more
New series of advanced freeze dryers
6 Feb 2019
The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation.Read more
Hitachi Chemical to acquire apceth Biopharma
5 Feb 2019
Acquisition will strengthen Hitachi's presence in the second-largest cell and gene therapy market in the world.Read more
FDA approves first generic Advair Diskus
4 Feb 2019
Mylan's Wixela Inhub is the first FDA-approved therapeutically equivalent generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or COPD.Read more
Sartorius joins the community of the National Institute for Innovation in Manufacturing Biopharmaceuticals
3 Feb 2019
Company hopes to contribute substantially to further optimizing and accelerating the current manufacturing processes in the biopharmaceutical industry.Read more
Particle Sciences partners with Encube Ethicals to develop novel vaginal rings
31 Jan 2019
The partnership will focus on rings for the administration of existing approved drugs, improving drug effectiveness and patient compliance.Read more
Manufacturing consultancy up 150% as life sciences prepare for a digital future
30 Jan 2019
Increasing appetite for digitised manufacturing and using data to improve GMP manufacturing.Read more
SGS expands testing capabilities at its Glasgow facility
29 Jan 2019
Clients will benefit from a fully comprehensive range of validated biosafety methods to support cell bank and viral vaccine manufacturing and lot release of drug product.Read more
BASF and B2B Cosmetics partner to enable individualized personal care products
28 Jan 2019
B2B Cosmetics will contribute their Emuage technology, which has received the “Innovation Award” at the trade show Consumer Electronics Show (CES) in Las Vegas.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation